Really only one thought C. And that is that the company already knows Voshkul's publication decision. Their hedging around that is unnecessary evasion. But all else is affirms their previously stated estimates/plan. Sounds good to me. I too would love their global reference to be Teva. Wouldn't we all? More snow! Time to shovel and get to the office. No longer feeling guilty for slacking off at the gym as this winter is giving me a great daily workout!
Market Data 
Markets 
AI
